Bleeding complications associated with dual antiplatelet therapy plus anticoagulant in patients who underwent percutaneous coronary intervention with drug-eluting stents

被引:0
|
作者
Uchida, Yoshie [1 ]
Tsurumi, Yukio [1 ]
Takahashi, Atsushi [1 ]
Higasitani, Michiaki [1 ]
Kameyama, Kinichi [1 ]
Nagashima, Michitaka [1 ]
Mori, Furmaki [1 ]
Takagi, Atsushi [1 ]
Shiga, Tsuyoshi [1 ]
Hagiwara, Nobuhisa [1 ]
Kasanuki, Hiroshi [1 ]
机构
[1] Tokyo Womens Med Univ, Tokyo, Japan
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
3474
引用
收藏
页码:786 / 786
页数:1
相关论文
共 50 条
  • [1] Compliance With Dual Antiplatelet Therapy Following Percutaneous Coronary Intervention With Drug-Eluting Stents
    de Sa, Daniel D. Correa
    Lennon, Ryan J.
    Bresnahan, John F.
    Rihal, Charanjit S.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 53 (10) : A371 - A371
  • [2] The optimal duration of dual antiplatelet therapy in patients receiving percutaneous coronary intervention with drug-eluting stents
    Sheyin, O.
    Perez, X.
    Pierre-Louis, B.
    Kurian, D.
    EUROPEAN HEART JOURNAL, 2015, 36 : 512 - 512
  • [3] The optimal duration of dual antiplatelet therapy in patients receiving percutaneous coronary intervention with drug-eluting stents
    Sheyin, Olusegun
    Perez, Xavier
    Bredy-Pierre-Louis
    Kurian, Damian
    CARDIOLOGY JOURNAL, 2016, 23 (03) : 307 - 316
  • [4] Impact of Anemia and Dual Antiplatelet Therapy on Mortality in Patients Undergoing Percutaneous Coronary Intervention with Drug-Eluting Stents
    Huili Wang
    Yuan Yang
    Lufeng Ma
    Xian Wang
    Jun Zhang
    Jinguo Fu
    Shouyan Zhang
    Ling Zhang
    Dayi Hu
    Rongjing Ding
    Scientific Reports, 5
  • [5] Impact of Anemia and Dual Antiplatelet Therapy on Mortality in Patients Undergoing Percutaneous Coronary Intervention with Drug-Eluting Stents
    Wang, Huili
    Yang, Yuan
    Ma, Lufeng
    Wang, Xian
    Zhang, Jun
    Fu, Jinguo
    Zhang, Shouyan
    Zhang, Ling
    Hu, Dayi
    Ding, Rongjing
    SCIENTIFIC REPORTS, 2015, 5
  • [6] Efficacy of Modified Dual Antiplatelet Therapy Combined with Warfarin Following Percutaneous Coronary Intervention with Drug-Eluting Stents
    Baber, Usman
    Akhter, Mohammed
    Kothari, Sharad
    Sharma, Samin K.
    Kini, Annapoorna
    JOURNAL OF INVASIVE CARDIOLOGY, 2010, 22 (02): : 80 - 83
  • [7] Impact of anticoagulant therapy with dual antiplatelet therapy on prognosis after treatment with drug-eluting coronary stents
    Uchida, Yoshie
    Mori, Fumiaki
    Ogawa, Hiroshi
    Takagi, Atsushi
    Hagiwara, Nobuhisa
    JOURNAL OF CARDIOLOGY, 2010, 55 (03) : 362 - 369
  • [8] Is there a safe time to stop clopidogrel in patients on dual antiplatelet therapy after a percutaneous coronary intervention and placement of drug-eluting stents?
    Almaddah, Nureddin
    Khouzam, Rami N.
    JOURNAL OF THORACIC DISEASE, 2017, 9 (12) : 4806 - 4807
  • [9] Impact of High-Responsiveness to Dual Antiplatelet Therapy on Bleeding Complications in Patients Receiving Drug-Eluting Stents
    Tsukahara, Kengo
    Kimura, Kazuo
    Morita, Satoshi
    Ebina, Toshiaki
    Kosuge, Masami
    Hibi, Kiyoshi
    Okuda, Jun
    Iwahashi, Noriaki
    Maejima, Nobuhiko
    Nakachi, Tatsuya
    Ohtsuka, Fumiyuki
    Hashiba, Katsutaka
    Tahara, Yoshio
    Sugano, Teruyasu
    Umemura, Satoshi
    CIRCULATION JOURNAL, 2010, 74 (04) : 679 - 685
  • [10] Dual Antiplatelet Therapy Duration in Patients With Drug-Eluting Stents
    Bondar, Maria
    Ilia, Mina
    Fletcher, Hollie
    US PHARMACIST, 2016, 41 (02) : HS2 - HS5